Ethinyl estradiol-cyproterone acetate versus low-dose pioglitazone- flutamide-metformin for adolescent girls with androgen excess: Divergent effects on CD163, TWEAK receptor, ANGPTL4, and LEPTIN Expression in subcutaneous adipose tissue

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 10, 2012, Pages 3630-3638

  Díaz, Marta ^a,c   Chacón, Matilde R ^b,c   López Bermejo, Abel ^d,e   Maymó Masip, Elsa ^b,c   Salvador, Cristina ^a   Vendrell, Joan ^b,c   De Zegher, Francis ^f   Ibáñez, Lourdes ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Department of Pediatrics   (Spain)

^e GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANGIOPOIETIN LIKE PROTEIN 4; C REACTIVE PROTEIN; CD163 ANTIGEN; CYPROTERONE ACETATE PLUS ETHINYLESTRADIOL; DIANE 35 DIARIO; FLUTAMIDA; FLUTAMIDE; FLUTAMIDE PLUS METFORMIN PLUS PIOGLITAZONE; LEPTIN; MEMBRANE PROTEIN; METFORMIN; METFORMINA; PIOFLUMET; PIOGLITAZONE; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY 12; UNCLASSIFIED DRUG;

ABDOMINAL FAT; ADOLESCENT; ARTERIAL WALL THICKNESS; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; HYPERANDROGENISM; HYPERINSULINEMIA; KIDNEY FUNCTION TEST; LIPID METABOLISM; LIPOPROTEIN METABOLISM; LIVER FUNCTION TEST; LOW DRUG DOSE; MACROPHAGE ACTIVATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT;

ABDOMINAL FAT; ADOLESCENT; ANDROGEN ANTAGONISTS; ANGIOPOIETINS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BODY COMPOSITION; CYPROTERONE ACETATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ETHINYL ESTRADIOL; FEMALE; FLUTAMIDE; GENE EXPRESSION; HUMANS; HYPERANDROGENISM; HYPOGLYCEMIC AGENTS; LEPTIN; METFORMIN; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; SUBCUTANEOUS FAT; THIAZOLIDINEDIONES;

EID: 84867258150     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1754     Document Type: Article

References (40)

1. Pfeifer SM, Kives S 2009 Polycystic ovary syndrome in the adolescent. Obstet Gynecol Clin North Am 36:129-152
2. Franks S 2008 Polycystic ovary syndrome in adolescents. Int J Obes (Lond) 32:1035-1041 (Pubitemid 351986206)
3. Dunaif A 2008 Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome - a reappraisal. Nat Clin Pract Endocrinol Metab 4:272-283 (Pubitemid 351571139)
4. Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, Lobo R, Norman RJ, Talbott E, Dumesic DA 2010 Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab 95:2038-2049
5. Ibáñez L, de Zegher F 2006 Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women. Hum Reprod Update 12:243-252
6. Ibáñez L, López-Bermejo A, del Rio L, Enríquez G, Valls C, de Zegher F 2007 Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess. J Clin Endocrinol Metab 92:1710-1714 (Pubitemid 46997176)
7. Mannerås-Holm L, Leonhardt H, Kullberg J, Jennische E, Odén A, Holm G, Hellström M, Lönn L, Olivecrona G, Stener-Victorin E, Lönn M 2011 Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. J Clin Endocrinol Metab 96:E304-E311
8. Cortón M, Botella-Carretero JI, Benguría A, Villuendas G, Zaballos A, San Millán JL, Escobar-Morreale HF, Peral B 2007 Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J Clin Endocrinol Metab 92:328-337 (Pubitemid 46075011)
9. Svendsen PF, Madsbad S, Nilas L, Paulsen SK, Pedersen SB 2009 Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome. Int J Obes (Lond) 33:1249-1256
10. Lecke SB, Mattei F, Morsch DM, Spritzer PM 2011 Abdominal subcutaneous fat gene expression and circulating levels of leptin and adiponectin in polycystic ovary syndrome. Fertil Steril 95:2044-2049
11. Lindholm A, Blomquist C, Bixo M, Dahlbom I, Hansson T, Sundström Poromaa I, Burén J 2011 No difference in markers of adipose tissue inflammation between overweight women with polycystic ovary syndrome and weight-matched controls. Hum Reprod 26:1478-1485
12. Chazenbalk G, Chen YH, Heneidi S, Lee JM, Pall M, Chen YD, Azziz R 2012 Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome. J Clin EndocrinolMetab97:E765-E770
13. Ibáñez L, Diaz M, Sebastiani G, Sánchez-Infantes D, Salvador C, Lopez-Bermejo A, de Zegher F 2011 Treatment of androgen excess in adolescent girls: ethinylestradiol-cyproteroneacetate versus low-dose pioglitazone-flutamide-metformin. J Clin Endocrinol Metab 96:3361-3366
14. Ibáñez L, Potau N, Zampolli M, Prat N, Virdis R, Vicens-Calvet E, Carrascosa A 1996 Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism. J Clin Endocrinol Metab 81:1237-1243 (Pubitemid 26083998)
15. Ibáñez L, López-Bermejo A, Díaz M, Marcos MV, de Zegher F 2011 Early metformin therapy (age 8-12 yr) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence. J Clin Endocrinol Metab 96:E1262-E1267
16. Schmittgen TD, Livak KJ 2008 Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3:1101-1108 (Pubitemid 351818697)
17. Møller HJ 2012 Soluble CD163. Scand J Clin Lab Invest 72:1-13
18. Lê KA, Mahurkar S, Alderete TL, Hasson RE, Adam TC, Kim JS, Beale E, Xie C, Greenberg AS, Allayee H, Goran MI 2011 Subcutaneous adipose tissue macrophage infiltration is associated with hepatic and visceral fat deposition, hyperinsulinemia, and stimulation of NF-κB stress pathway. Diabetes 60:2802-2809
19. Farb MG, Bigornia S, Mott M, Tanriverdi K, Morin KM, Freedman JE, Joseph L, Hess DT, Apovian CM, Vita JA, Gokce N 2011 Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity. J Am Coll Cardiol 58:232-237
20. Bover LC, Cardó-Vila M, Kuniyasu A, Sun J, Rangel R, Takeya M, Aggarwal BB, Arap W, Pasqualini R 2007 A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications. J Immunol 178:8183-8194 (Pubitemid 46898091)
21. Winkles JA 2008 The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nat Rev Drug Discov 7:411-425 (Pubitemid 351619113)
22. Vendrell J, Maymó-Masip E, Tinahones F, García-España A, Megia A, Caubet E, García-Fuentes E, Chacón MR 2010 Tumor necrosis-like weak inducer of apoptosis as a proinflammatory cytokine in human adipocyte cells: up-regulation in severe obesity is mediated by inflammation but not hypoxia. J Clin Endocrinol Metab 95:2983-2992
23. Sporrer D, Weber M, Wanninger J, Weigert J, Neumeier M, Stógbauer F, Lieberer E, Bala M, Kopp A, Scháffler A, Buechler C 2009 Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity. Eur J Clin Invest 39:671-679
24. Sag D, Carling D, Stout RD, Suttles J 2008 Adenosine 5′- monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J Immunol 181:8633-8641
25. Boyle JG, Logan PJ, Jones GC, Small M, Sattar N, Connell JM, Cleland SJ, Salt IP 2011 AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study. Diabetologia 54:1799-1809
26. Lichtenstein L, Berbée JF, van Dijk SJ, van Dijk KW, Bensadoun A, Kema IP, Voshol PJ, Müller M, Rensen PC, Kersten S 2007 Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake. Arterioscler Thromb Vasc Biol 27:2420-2427 (Pubitemid 350203959)
27. Mattijssen F, Kersten S 2012 Regulation of triglyceride metabolism by angiopoietin-like proteins. Biochim Biophys Acta 1821:782-789
28. Adachi H, Fujiwara Y, Kondo T, Nishikawa T, Ogawa R, Matsumura T, Ishii N, Nagai R, Miyata K, Tabata M, Motoshima H, Furukawa N, Tsuruzoe K, Kawashima J, Takeya M, Yamashita S, Koh GY, Nagy A, Suda T, Oike Y, Araki E 2009 Angptl 4 deficiency improves lipid metabolism, suppresses foam cell formation and protects against atherosclerosis. Biochem Biophys Res Commun 379:806-811
29. Mizutani N, Ozaki N, Seino Y, Fukami A, Sakamoto E, Fukuyama T, Sugimura Y, Nagasaki H, Arima H, Oiso Y 2012 Reduction of insulin signaling upregulates angiopoietin-like protein 4 through elevated free fatty acids in diabetic mice. Exp Clin Endocrinol Diabetes 120:139-144
30. Choi JH, Banks AS, Estall JL, Kajimura S, Boström P, Laznik D, Ruas JL, Chalmers MJ, Kamenecka TM, Blüher M, Griffin PR, Spiegelman BM 2010 Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5. Nature 466:451-456
31. Carmina E, ChuMC,Moran C, Tortoriello D, Vardhana P, Tena G, Preciado R, Lobo R 2008 Subcutaneous and omental fat expression of adiponectin and leptin inwomenwith polycystic ovary syndrome. Fertil Steril 89:642-648 (Pubitemid 351337665)
32. You T, Yang R, Lyles MF, Gong D, Nicklas BJ 2005 Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors. Am J Physiol Endocrinol Metab 288:E741-E747 (Pubitemid 40397209)
33. Skopková M, Penesová A, Sell H, Rádiková Z, Vlcek M, Imrich R, Koska J, Ukropec J, Eckel J, Klimes I, Gasperí ková D 2007 Protein array reveals differentially expressed proteins in subcutaneous adipose tissue in obesity. Obesity (Silver Spring) 15:2396-2406 (Pubitemid 350034033)
34. Ceddia RB, William Jr WN, Lima FB, Curi R 1998 Leptin inhibits insulin-stimulated incorporation of glucose into lipids and stimulates glucose decarboxylation in isolated rat adipocytes. J Endocrinol 158:R7-R9 (Pubitemid 28407554)
35. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS 1997 Tumor necrosis factor-α contributes to obesityrelated hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 100:2777-2782 (Pubitemid 28007546)
36. Baudrand R, Domínguez JM, Carvajal CA, Riquelme A, Campino C, Macchiavello S, Bozinovic M, Morales M, Pizarro M, Solis N, Escalona A, Boza C, Arrese M, Fardella CE 2011 Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients. Metabolism 60:1775-1780
37. McInnes KJ, Brown KA, Hunger NI, Simpson ER 30 August 2011 Regulation of LKB1 expression by sex hormones in adipocytes. Int J Obes (Lond) doi: 10.1038/ijo.2011.172
38. López-Bermejo A, Díaz M, Morán E, de Zegher F, Ibáñez L 2010 A single nucleotide polymorphism in STK11 influences insulin sensitivity and metformin efficacy in hyperinsulinemic girls with androgen excess. Diabetes Care 33:1544-1548
39. Laybutt DR, Preston AM, Akerfeldt MC, Kench JG, Busch AK, Biankin AV, Biden TJ 2007 Endoplasmic reticulum stress contributes to β cell apoptosis in type 2 diabetes. Diabetologia 50:752-763 (Pubitemid 46355827)
40. Song XJ, Yang CY, Liu B, Wei Q, Korkor MT, Liu JY, Yang P 2011 Atorvastatin inhibits myocardial cell apoptosis in a rat model with post-myocardial infarction heart failure by downregulating ER stress response. Int J Med Sci 8:564-572